New concepts in the immunopathogenesis of chronic hepatitis B: The importance of the innate immune response

Hepatology International

Volumn 2, Issue SUPPL. 1, 2008, Pages

  Ratnam, Dilip ^a,b   Visvanathan, Kumar ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

Chronic Hepatitis B; Dendritic cells; Hepatitis B; Immunopathogenesis; Toll like receptor

Indexed keywords

HEPATITIS B(E) ANTIGEN; MANNOSE BINDING LECTIN; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR; VIRUS DNA;

ACUTE HEPATITIS; ARTICLE; CHRONIC HEPATITIS; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE COURSE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOPATHOGENESIS; INNATE IMMUNITY; KUPFFER CELL; LIVER CELL; LIVER CELL CARCINOMA; LIVER FIBROSIS; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; RISK FACTOR; VIRUS CELL INTERACTION; VIRUS REPLICATION;

EID: 69749087855     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-008-9067-0     Document Type: Article

References (65)

1. 1. D Ganem AM Prince 2004 Hepatitis B virus infection—natural history and clinical consequences N Engl J Med 350 1118 29 15014185 10.1056/NEJMra031087 1:CAS:528:DC%2BD2cXitV2qurs%3D Ganem D, Prince AM. Hepatitis B virus infection—natural history and clinical consequences. N Engl J Med. 2004;350:1118–29.
2. 2. AS Lok BJ McMahon 2007 Chronic hepatitis B Hepatology 45 507 39 17256718 10.1002/hep.21513 1:CAS:528:DC%2BD2sXisVKns7o%3D Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45:507–39.
3. 3. C Ferrari A Penna A Bertoletti A Valli AD Antoni T Giuberti 1990 Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection J Immunol 145 3442 9 2230128 1:CAS:528:DyaK3MXksFer Ferrari C, Penna A, Bertoletti A, Valli A, Antoni AD, Giuberti T, et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol. 1990;145:3442–9.
4. 4. B Rehermann P Fowler J Sidney J Person A Redeker M Brown 1995 The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis J Exp Med 181 1047 58 7532675 10.1084/jem.181.3.1047 1:CAS:528:DyaK2MXjvVWlur8%3D Rehermann B, Fowler P, Sidney J, Person J, Redeker A, Brown M, et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med. 1995;181:1047–58.
5. 5. R Thimme S Wieland C Steiger J Ghrayeb KA Reimann RH Purcell 2003 CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection J Virol 77 68 76 12477811 10.1128/JVI.77.1.68-76.2003 1:CAS:528:DC%2BD3sXkt1Sn Thimme R, Wieland S, Steiger C, Ghrayeb J, Reimann KA, Purcell RH, et al. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol. 2003;77:68–76.
6. 6. B Beutler 2004 Innate immunity: an overview Mol Immunol 40 845 59 14698223 10.1016/j.molimm.2003.10.005 1:CAS:528:DC%2BD3sXpvFegu7c%3D Beutler B. Innate immunity: an overview. Mol Immunol. 2004;40:845–59.
7. 7. B Beutler 2004 Inferences, questions and possibilities in Toll-like receptor signalling Nature 430 257 63 15241424 10.1038/nature02761 1:CAS:528:DC%2BD2cXlsVGjt7g%3D Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature. 2004;430:257–63.
8. 8. R Medzhitov C Janeway Jr 2000 Innate immunity N Engl J Med 343 338 44 10922424 10.1056/NEJM200008033430506 1:CAS:528:DC%2BD3cXlvVOltbs%3D Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med. 2000;343:338–44.
9. 9. RF Schwabe E Seki DA Brenner 2006 Toll-like receptor signaling in the liver Gastroenterology 130 1886 900 16697751 10.1053/j.gastro.2006.01.038 1:CAS:528:DC%2BD28Xls1Wit7s%3D Schwabe RF, Seki E, Brenner DA. Toll-like receptor signaling in the liver. Gastroenterology. 2006;130:1886–900.
10. 10. G Szabo A Dolganiuc P Mandrekar 2006 Pattern recognition receptors: a contemporary view on liver diseases Hepatology 44 287 98 16871558 10.1002/hep.21308 1:CAS:528:DC%2BD28XptVKmt74%3D Szabo G, Dolganiuc A, Mandrekar P. Pattern recognition receptors: a contemporary view on liver diseases. Hepatology. 2006;44:287–98.
11. 11. KA Zarember PJ Godowski 2002 Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines J Immunol 168 554 61 11777946 1:CAS:528:DC%2BD38XksFWntg%3D%3D Zarember KA, Godowski PJ. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol. 2002;168:554–61.
12. 12. V Hornung S Rothenfusser S Britsch A Krug B Jahrsdorfer T Giese 2002 Quantitative expression of toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides J Immunol 168 4531 7 11970999 1:CAS:528:DC%2BD38Xjt12jt7k%3D Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, et al. Quantitative expression of toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol. 2002;168:4531–7.
13. 13. N Inohara G Nunez 2003 NODS: Intracellular proteint involved in inflammation and apopotosis Nat Rev 3 371 82 1:CAS:528:DC%2BD3sXjvF2mt7k%3D 10.1038/nri1086 Inohara N, Nunez G. NODS: Intracellular proteint involved in inflammation and apopotosis. Nat Rev. 2003;3:371–82.
14. 14. S Akira 2003 Toll-like receptor signaling J Biol Chem 278 38105 8 12893815 10.1074/jbc.R300028200 1:CAS:528:DC%2BD3sXnslSqtr8%3D Akira S. Toll-like receptor signaling. J Biol Chem. 2003;278:38105–8.
15. 15. B Beutler K Hoebe X Du RJ Ulevitch 2003 How we detect microbes and respond to them: the Toll-like receptors and their transducers J Leukoc Biol 74 479 85 12960260 10.1189/jlb.0203082 1:CAS:528:DC%2BD3sXotlGktL0%3D Beutler B, Hoebe K, Du X, Ulevitch RJ. How we detect microbes and respond to them: the Toll-like receptors and their transducers. J Leukoc Biol. 2003;74:479–85.
16. 16. KW Boehme T Compton 2004 Innate sensing of viruses by toll-like receptors J Virol 78 7867 73 15254159 10.1128/JVI.78.15.7867-7873.2004 1:CAS:528:DC%2BD2cXmtFequ74%3D Boehme KW, Compton T. Innate sensing of viruses by toll-like receptors. J Virol. 2004;78:7867–73.
17. 17. AG Bowie 2007 Translational mini-review series on Toll-like receptors: recent advances in understanding the role of Toll-like receptors in anti-viral immunity Clin Exp Immunol 147 217 26 17223961 1:CAS:528:DC%2BD2sXjtFChurs%3D 10.1111/j.1365-2249.2006.03301.x Bowie AG. Translational mini-review series on Toll-like receptors: recent advances in understanding the role of Toll-like receptors in anti-viral immunity. Clin Exp Immunol. 2007;147:217–26.
18. 18. GM Barton 2007 Viral recognition by Toll-like receptors Semin Immunol 19 33 40 17336545 10.1016/j.smim.2007.01.003 1:CAS:528:DC%2BD2sXjslGrsb4%3D Barton GM. Viral recognition by Toll-like receptors. Semin Immunol. 2007;19:33–40.
19. 19. GJ Webster S Reignat MK Maini SA Whalley GS Ogg A King 2000 Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms Hepatology 32 1117 24 11050064 10.1053/jhep.2000.19324 1:STN:280:DC%2BD3M%2FivFagug%3D%3D Webster GJ, Reignat S, Maini MK, Whalley SA, Ogg GS, King A, et al. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology. 2000;32:1117–24.
20. 20. LG Guidotti R Rochford J Chung M Shapiro R Purcell FV Chisari 1999 Viral clearance without destruction of infected cells during acute HBV infection Science 284 825 9 10221919 10.1126/science.284.5415.825 1:CAS:528:DyaK1MXivVKqsLk%3D Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science. 1999;284:825–9.
21. 21. S Wieland R Thimme RH Purcell FV Chisari 2004 Genomic analysis of the host response to hepatitis B virus infection Proc Natl Acad Sci USA 101 6669 74 15100412 10.1073/pnas.0401771101 1:CAS:528:DC%2BD2cXjvVyhsr8%3D Wieland S, Thimme R, Purcell RH, Chisari FV. Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci USA. 2004;101:6669–74.
22. 22. CB Bigger KM Brasky RE Lanford 2001 DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection J Virol 75 7059 66 11435586 10.1128/JVI.75.15.7059-7066.2001 1:CAS:528:DC%2BD3MXlsVCgsrc%3D Bigger CB, Brasky KM, Lanford RE. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol. 2001;75:7059–66.
23. 23. AI Su JP Pezacki L Wodicka AD Brideau L Supekova R Thimme 2002 Genomic analysis of the host response to hepatitis C virus infection Proc Natl Acad Sci USA 99 15669 74 12441396 10.1073/pnas.202608199 1:CAS:528:DC%2BD3sXjvFSj Su AI, Pezacki JP, Wodicka L, Brideau AD, Supekova L, Thimme R, et al. Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci USA. 2002;99:15669–74.
24. 24. A Bertoletti AJ Gehring 2006 The immune response during hepatitis B virus infection J Gen Virol 87 Pt 6 1439 49 16690908 10.1099/vir.0.81920-0 1:CAS:528:DC%2BD28XlvFCjurw%3D Bertoletti A, Gehring AJ. The immune response during hepatitis B virus infection. J Gen Virol. 2006;87 Pt 6:1439–49.
25. 25. B Rehermann M Nascimbeni 2005 Immunology of hepatitis B virus and hepatitis C virus infection Nat Rev Immunol 5 215 29 15738952 10.1038/nri1573 1:CAS:528:DC%2BD2MXhslSju7k%3D Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol. 2005;5:215–29.
26. 26. M Isogawa MD Robek Y Furuichi FV Chisari 2005 Toll-like receptor signaling inhibits hepatitis B virus replication in vivo J Virol 79 7269 72 15890966 10.1128/JVI.79.11.7269-7272.2005 1:CAS:528:DC%2BD2MXksFKgtr0%3D Isogawa M, Robek MD, Furuichi Y, Chisari FV. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol. 2005;79:7269–72.
27. 27. H McClary R Koch FV Chisari LG Guidotti 2000 Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines J Virol 74 2255 64 10666256 10.1128/JVI.74.5.2255-2264.2000 1:CAS:528:DC%2BD3cXhtF2kt7g%3D McClary H, Koch R, Chisari FV, Guidotti LG. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J Virol. 2000;74:2255–64.
28. 28. SF Wieland LG Guidotti FV Chisari 2000 Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice J Virol 74 4165 73 10756029 10.1128/JVI.74.9.4165-4173.2000 1:CAS:528:DC%2BD3cXislGrurk%3D Wieland SF, Guidotti LG, Chisari FV. Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice. J Virol. 2000;74:4165–73.
29. 29. LG Guidotti FV Chisari 2001 Noncytolytic control of viral infections by the innate and adaptive immune response Annu Rev Immunol 19 65 91 11244031 10.1146/annurev.immunol.19.1.65 1:CAS:528:DC%2BD3MXivFKgtb0%3D Guidotti LG, Chisari FV. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol. 2001;19:65–91.
30. 30. S Liu DJ Gallo AM Green DL Williams X Gong RA Shapiro 2002 Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide Infect Immun 70 3433 42 12065483 10.1128/IAI.70.7.3433-3442.2002 1:CAS:528:DC%2BD38XkvV2luro%3D Liu S, Gallo DJ, Green AM, Williams DL, Gong X, Shapiro RA, et al. Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide. Infect Immun. 2002;70:3433–42.
31. 31. K Li Z Chen N Kato M Gale Jr SM Lemon 2005 Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes J Biol Chem 280 16739 47 15737993 10.1074/jbc.M414139200 1:CAS:528:DC%2BD2MXjsFOgs7g%3D Li K, Chen Z, Kato N, Gale M Jr, Lemon SM. Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J Biol Chem. 2005;280:16739–47.
32. 32. T Matsumura T Degawa T Takii H Hayashi T Okamoto J Inoue 2003 TRAF6-NF-kappaB pathway is essential for interleukin-1-induced TLR2 expression and its functional response to TLR2 ligand in murine hepatocytes Immunology 109 127 36 12709026 10.1046/j.1365-2567.2003.01627.x 1:CAS:528:DC%2BD3sXjvVertLw%3D Matsumura T, Degawa T, Takii T, Hayashi H, Okamoto T, Inoue J, et al. TRAF6-NF-kappaB pathway is essential for interleukin-1-induced TLR2 expression and its functional response to TLR2 ligand in murine hepatocytes. Immunology. 2003;109:127–36.
33. 33. CA Biron KB Nguyen GC Pien LP Cousens TP Salazar-Mather 1999 Natural killer cells in antiviral defense: function and regulation by innate cytokines Annu Rev Immunol 17 189 220 10358757 10.1146/annurev.immunol.17.1.189 1:CAS:528:DyaK1MXjtVSrtbo%3D Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol. 1999;17:189–220.
34. 34. AO Dokun DT Chu L Yang AS Bendelac WM Yokoyama 2001 Analysis of in situ NK cell responses during viral infection J Immunol 167 5286 93 11673544 1:CAS:528:DC%2BD3MXotVWjsbk%3D Dokun AO, Chu DT, Yang L, Bendelac AS, Yokoyama WM. Analysis of in situ NK cell responses during viral infection. J Immunol. 2001;167:5286–93.
35. 35. S Norris C Collins DG Doherty F Smith G McEntee O Traynor 1998 Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes J Hepatol 28 84 90 9537869 10.1016/S0168-8278(98)80206-7 1:CAS:528:DyaK1cXmvVWgtLg%3D Norris S, Collins C, Doherty DG, Smith F, McEntee G, Traynor O, et al. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J Hepatol. 1998;28:84–90.
36. 36. C Dunn M Brunetto G Reynolds T Christophides PT Kennedy P Lampertico 2007 Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage J Exp Med 204 667 80 17353365 10.1084/jem.20061287 1:CAS:528:DC%2BD2sXjsVyqsrY%3D Dunn C, Brunetto M, Reynolds G, Christophides T, Kennedy PT, Lampertico P, et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med. 2007;204:667–80.
37. 37. Z Trobonjaca F Leithauser P Moller R Schirmbeck J Reimann 2001 Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells J Immunol 167 1413 22 11466360 1:CAS:528:DC%2BD3MXls1Wku7Y%3D Trobonjaca Z, Leithauser F, Moller P, Schirmbeck R, Reimann J. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells. J Immunol. 2001;167:1413–22.
38. 38. G Sitia M Isogawa M Iannacone IL Campbell FV Chisari LG Guidotti 2004 MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs J Clin Invest 113 1158 67 15085195 1:CAS:528:DC%2BD2cXjt1yisL4%3D Sitia G, Isogawa M, Iannacone M, Campbell IL, Chisari FV, Guidotti LG. MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs. J Clin Invest. 2004;113:1158–67.
39. 39. K Kimura K Kakimi S Wieland LG Guidotti FV Chisari 2002 Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice J Virol 76 10702 7 12368312 10.1128/JVI.76.21.10702-10707.2002 1:CAS:528:DC%2BD38XnvFGqu7g%3D Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J Virol. 2002;76:10702–7.
40. 40. K Kakimi LG Guidotti Y Koezuka FV Chisari 2000 Natural killer T cell activation inhibits hepatitis B virus replication in vivo J Exp Med 192 921 30 11015434 10.1084/jem.192.7.921 1:CAS:528:DC%2BD3cXntFSltro%3D Kakimi K, Guidotti LG, Koezuka Y, Chisari FV. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med. 2000;192:921–30.
41. 41. LL Lanier 1998 NK cell receptors Annu Rev Immunol 16 359 93 9597134 10.1146/annurev.immunol.16.1.359 1:CAS:528:DyaK1cXislynt7s%3D Lanier LL. NK cell receptors. Annu Rev Immunol. 1998;16:359–93.
42. 42. K Kimura K Kakimi S Wieland LG Guidotti FV Chisari 2002 Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice J Immunol 169 5188 95 12391236 Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV. Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice. J Immunol. 2002;169:5188–95.
43. 43. GL Su RD Klein A Aminlari HY Zhang L Steinstraesser WH Alarcon 2000 Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and toll-like receptor 4 Hepatology 31 932 6 10733550 10.1053/he.2000.5634 1:CAS:528:DC%2BD3cXis1Cks78%3D Su GL, Klein RD, Aminlari A, Zhang HY, Steinstraesser L, Alarcon WH, et al. Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and toll-like receptor 4. Hepatology. 2000;31:932–6.
44. 44. E Seki H Tsutsui H Nakano N Tsuji K O Hoshino Adachi 2001 Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1beta J Immunol 166 2651 7 11160328 1:CAS:528:DC%2BD3MXht1Ghsro%3D Seki E, Tsutsui H, Nakano H, Tsuji N, Hoshino K, Adachi O, et al. Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1beta. J Immunol. 2001;166:2651–7.
45. 45. K M Kopydlowski CA Salkowski MJ Cody N Rooijen van J Major TA Hamilton 1999 Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo J Immunol 163 1537 44 10415057 1:CAS:528:DyaK1MXkslOgsLs%3D Kopydlowski KM, Salkowski CA, Cody MJ, van Rooijen N, Major J, Hamilton TA, et al. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. J Immunol. 1999;163:1537–44.
46. 46. K Kakimi TE Lane FV Chisari LG Guidotti 2001 Cutting edge: Inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver J Immunol 167 6701 5 11739482 1:CAS:528:DC%2BD3MXptFGitrk%3D Kakimi K, Lane TE, Chisari FV, Guidotti LG. Cutting edge: Inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver. J Immunol. 2001;167:6701–5.
47. 47. V Pasquetto LG Guidotti K Kakimi M Tsuji FV Chisari 2000 Host-virus interactions during malaria infection in hepatitis B virus transgenic mice J Exp Med 192 529 36 10952722 10.1084/jem.192.4.529 1:CAS:528:DC%2BD3cXlvFems7c%3D Pasquetto V, Guidotti LG, Kakimi K, Tsuji M, Chisari FV. Host-virus interactions during malaria infection in hepatitis B virus transgenic mice. J Exp Med. 2000;192:529–36.
48. 48. J Banchereau RM Steinman 1998 Dendritic cells and the control of immunity Nature 392 245 52 9521319 10.1038/32588 1:CAS:528:DyaK1cXitFWrsr8%3D Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245–52.
49. 49. T Ito H Kanzler O Duramad W Cao YJ Liu 2006 Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells Blood 107 2423 31 16293610 10.1182/blood-2005-07-2709 1:CAS:528:DC%2BD28XisFOjur4%3D Ito T, Kanzler H, Duramad O, Cao W, Liu YJ. Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells. Blood. 2006;107:2423–31.
50. 50. A Penna M Artini A Cavalli M Levrero A Bertoletti M Pilli 1996 Long-lasting memory T cell responses following self-limited acute hepatitis B J Clin Invest 98 1185 94 8787682 10.1172/JCI118902 1:CAS:528:DyaK28XlsFaktrk%3D Penna A, Artini M, Cavalli A, Levrero M, Bertoletti A, Pilli M, et al. Long-lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest. 1996;98:1185–94.
51. 51. A Penna G Prete Del A Cavalli A Bertoletti MM D’Elios R Sorrentino 1997 Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B Hepatology 25 1022 7 9096614 10.1002/hep.510250438 1:CAS:528:DyaK2sXislejurg%3D Penna A, Del Prete G, Cavalli A, Bertoletti A, D’Elios MM, Sorrentino R, et al. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology. 1997;25:1022–7.
52. 52. A Bertoletti NV Naoumov 2003 Translation of immunological knowledge into better treatments of chronic hepatitis B J Hepatol 39 115 24 12821053 10.1016/S0168-8278(03)00126-0 Bertoletti A, Naoumov NV. Translation of immunological knowledge into better treatments of chronic hepatitis B. J Hepatol. 2003;39:115–24.
53. 53. SM Riordan N Skinner J Kurtovic S Locarnini K Visvanathan 2006 Reduced expression of toll-like receptor 2 on peripheral monocytes in patients with chronic hepatitis B Clin Vaccine Immunol 13 972 4 16894001 10.1128/CVI.00396-05 1:CAS:528:DC%2BD28XosFCrtro%3D Riordan SM, Skinner N, Kurtovic J, Locarnini S, Visvanathan K. Reduced expression of toll-like receptor 2 on peripheral monocytes in patients with chronic hepatitis B. Clin Vaccine Immunol. 2006;13:972–4.
54. 54. K Visvanathan NA Skinner AJ Thompson SM Riordan V Sozzi R Edwards 2007 Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein Hepatology 45 102 10 17187404 10.1002/hep.21482 1:CAS:528:DC%2BD2sXht1arsbk%3D Visvanathan K, Skinner NA, Thompson AJ, Riordan SM, Sozzi V, Edwards R, et al. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology. 2007;45:102–10.
55. 55. J Cheng H Imanishi H Morisaki W Liu H Nakamura T Morisaki 2005 Recombinant HBsAg inhibits LPS-induced COX-2 expression and IL-18 production by interfering with the NFkappaB pathway in a human monocytic cell line,THP-1 J Hepatol 43 465 71 15963597 10.1016/j.jhep.2005.02.033 1:CAS:528:DC%2BD2MXntVCku70%3D Cheng J, Imanishi H, Morisaki H, Liu W, Nakamura H, Morisaki T, et al. Recombinant HBsAg inhibits LPS-induced COX-2 expression and IL-18 production by interfering with the NFkappaB pathway in a human monocytic cell line,THP-1. J Hepatol. 2005;43:465–71.
56. 56. WP Chong YF To WK Ip MF Yuen TP Poon WH Wong 2005 Mannose-binding lectin in chronic hepatitis B virus infection Hepatology 42 1037 45 16231358 10.1002/hep.20891 1:CAS:528:DC%2BD2MXht1amtbrI Chong WP, To YF, Ip WK, Yuen MF, Poon TP, Wong WH, et al. Mannose-binding lectin in chronic hepatitis B virus infection. Hepatology. 2005;42:1037–45.
57. 57. CL Thio T Mosbruger J Astemborski S Greer GD Kirk SJ O’Brien 2005 Mannose binding lectin genotypes influence recovery from hepatitis B virus infection J Virol 79 9192 6 15994813 10.1128/JVI.79.14.9192-9196.2005 1:CAS:528:DC%2BD2MXmtFOjt74%3D Thio CL, Mosbruger T, Astemborski J, Greer S, Kirk GD, O’Brien SJ, et al. Mannose binding lectin genotypes influence recovery from hepatitis B virus infection. J Virol. 2005;79:9192–6.
58. 58. S Tavakoli W Schwerin A Rohwer S Hoffmann S Weyer R Weth 2004 Phenotype and function of monocyte derived dendritic cells in chronic hepatitis B virus infection J Gen Virol 85 2829 36 15448344 10.1099/vir.0.80143-0 1:CAS:528:DC%2BD2cXosV2gsLs%3D Tavakoli S, Schwerin W, Rohwer A, Hoffmann S, Weyer S, Weth R, et al. Phenotype and function of monocyte derived dendritic cells in chronic hepatitis B virus infection. J Gen Virol. 2004;85:2829–36.
59. 59. RG Molen van der D Sprengers RS Binda EC Jong de HG Niesters JG Kusters 2004 Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B Hepatology 40 738 46 15349914 10.1002/hep.20366 van der Molen RG, Sprengers D, Binda RS, de Jong EC, Niesters HG, Kusters JG, et al. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology. 2004;40:738–46.
60. 60. S Beckebaum VR Cicinnati G Dworacki J Muller-Berghaus D Stolz J Harnaha 2002 Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection Clin Immunol 104 138 50 12165275 10.1006/clim.2002.5245 1:CAS:528:DC%2BD38XnvFCmt7c%3D Beckebaum S, Cicinnati VR, Dworacki G, Muller-Berghaus J, Stolz D, Harnaha J, et al. Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. Clin Immunol. 2002;104:138–50.
61. 61. K Wang X Fan Y Fan B Wang L Han Y Hou 2007 Study on the function of circulating plasmacytoid dendritic cells in the immunoactive phase of patients with chronic genotype B and C HBV infection J Viral Hepatitis 14 276 82 10.1111/j.1365-2893.2006.00819.x 1:STN:280:DC%2BD2s7otFOqsA%3D%3D Wang K, Fan X, Fan Y, Wang B, Han L, Hou Y. Study on the function of circulating plasmacytoid dendritic cells in the immunoactive phase of patients with chronic genotype B and C HBV infection. J Viral Hepatitis. 2007;14:276–82.
62. 62. XZ Duan M Wang HW Li H Zhuang D Xu FS Wang 2004 Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans J Clin Immunol 24 637 46 15622448 10.1007/s10875-004-6249-y 1:CAS:528:DC%2BD2MXhtFSgtA%3D%3D Duan XZ, Wang M, Li HW, Zhuang H, Xu D, Wang FS. Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans. J Clin Immunol. 2004;24:637–46.
63. 63. A Hasebe SM Akbar S Furukawa N Horiike M Onji 2005 Impaired functional capacities of liver dendritic cells from murine hepatitis B virus (HBV) carriers: relevance to low HBV-specific immune responses Clin Exp Immunol 139 35 42 15606611 10.1111/j.1365-2249.2005.02676.x 1:CAS:528:DC%2BD2MXhtFWmsbw%3D Hasebe A, Akbar SM, Furukawa S, Horiike N, Onji M. Impaired functional capacities of liver dendritic cells from murine hepatitis B virus (HBV) carriers: relevance to low HBV-specific immune responses. Clin Exp Immunol. 2005;139:35–42.
64. 64. Y Chen R Sun W Jiang H Wei Z Tian 2007 Liver-specific HBsAg transgenic mice are over-sensitive to poly(I:C)-induced liver injury in NK cell-and IFN-γ-dependent manner J Hepatol 47 183 90 17448568 10.1016/j.jhep.2007.02.020 1:CAS:528:DC%2BD2sXnsFKgtLw%3D Chen Y, Sun R, Jiang W, Wei H, Tian Z. Liver-specific HBsAg transgenic mice are over-sensitive to poly(I:C)-induced liver injury in NK cell-and IFN-γ-dependent manner. J Hepatol. 2007;47:183–90.
65. 65. Chen Y, Wei H, Sun R, Dong Z, Zhang J, Tian Z. Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells. Hepatology. 2007;46:706–15.